Cochlear dysfunction and microvascular complications in patients with type 1 diabetes mellitus

Abstract

Sensorineural hearing impairment has been associated with DM, and it is probably linked to the same pathophysiological mechanisms as well-established in microvascular diabetes complications. The study of otoacoustic emissions (OAEs) is useful to identify subclinical cochlear dysfunction. Therefore, the aim of this study was to evaluate the association between abnormal OAEs responses, diabetic kidney disease (DKD) and diabetic cardiac autonomic neuropathy (CAN). We performed a cross-sectional study with 37 type 1 DM patients without auditory symptoms, submitted to the study of Distortion Product Otoacoustic Emissions (DPOAEs) and screened for DKD and CAN. The otoacoustic emissions responses were considered abnormal in 27/37 (73%) patients. A correlation was found between abnormal OAEs responses and presence of DKD (r = 0.36, p < 0.05), and 14/16 (88%) patients with a lower amplitude of OAEs in 8 kHz frequency band presented DKD. Abnormal OAEs responses in the 6 kHz frequency band were correlated with the presence (r = 0.41, p = 0.01) and severity of CAN (r = 0.44, p < 0.001). Additionally, 7/9 (78%) patients with abnormal OAE responses in this frequency also presented abnormal CAN scores. Our results suggest that abnormal otoacoustic emissions responses in high frequency bands are associated with diabetes microvascular complications and could be a risk marker for DKD and CAN, presenting low sensitivity and high specificity. Therefore, assuming that hearing impairment is a pre-clinical stage of hearing loss, performing distortion product otoacoustic emissions in T1DM patients with microvascular complications could be useful to identify those who would be benefit with regular audiologic follow up and tighter diabetes control.

Association Between Tinnitus and Hypertension: A Cross-Sectional Analysis of the National Health and Nutrition Examination Survey

“…Furthermore, the association between tinnitus and hypertension found in participants aged 20 to 39 is accompanied with an association of diabetes and hypertension as well. Diabetes has also been shown to cause microangiopathic degeneration damaging the stria vascularis of the cochlea leading to clinical hearing loss (24,25). Interestingly, Dehkordi et al showed that patients with hypertension and/or diabetes had some relief from their tinnitus when treated with gabapentin.…”

Impaired Glycolysis Promotes Alcohol Exposure-Induced Apoptosis in HEI-OC1 Cells via Inhibition of EGFR Signaling

“…Since the normal functions of hair cells require high levels of glucose and ATP for the modulation of hearing [42], the impairment of glucose metabolism related to diabetes mellitus (DM) might be associated with patients with hearing loss [43,44]. Previous studies have shown that the relationship between diabetes and hearing dysfunction [43,44].…”

Understanding the Relationship Between Age-Related Hearing Loss and Alzheimer’s Disease: A Narrative Review

“…Microvascular complications are common feature in both ARHL and dementia. Research suggests that diabetes mellitus, which is characterized by many microvascular complication, is a common risk factor for both hearing loss [ 82, 83 ] and dementia [ 3, 84 ].…”